World’s First Ever Generic Version of Oral Ledipasvir + Sofosbuvir Tablet Introduced in Bangladesh Market. Incepta Pharmaceuticals launched the world’s first ever generic drug of Ledipasvir + Sofosbuvir tablet in Bangladesh market.
In fact it is only generic drug of this combination available in world market. Since its launching it has generated huge interest throughout the world. Like previously launched Hopetavir (generic drug of Sofosbuvir), it was also launched at 99% discount price compared to innovator’s brand.
Twinvir is mainly indicated for the treatment of Hepatitis C genotype 1/4/6 infection. With this treatment option there is no need of either Interferon or Ribavirin. One tablet once a day is sufficient for the treatment of Hepatitis C. Twinvir provides high cure rate, less daily tablet burden, less complicated treatment regimens and also more affordable to the patients.
In addition to local market, Incepta hopes to launch this product to international market in near future.
Incepta Pharmaceuticals Ltd. is a leading pharmaceutical company in Bangladesh established in the year 1999. The company has a very big manufacturing facility located at Savar, 35 kilometer away from the center of the capital city Dhaka. The company produces various types of dosage forms which include tablets, capsules, oral liquids, ampoules, dry powder vials, powder for suspension, nasal sprays, eye drops, creams, ointments, lotions, gels, prefilled syringes, liquid filled hard gelatin capsules, lyophilized injections, human vaccine etc. Since its inception, Incepta has been launching new and innovative products in order to fulfill unmet demand of the medical community. The focus has been to bring more new technologically advanced molecules to this country.